Royalty Pharma Acquires Royalty Interest in Alnylam’s AMVUTTRA for $310 Million from Blackstone Life Sciences

AMVUTTRA is an FDA-approved RNAi therapeutic for the treatment of ATTR amyloidosis, a progressive, degenerative and fatal disease caused by misfolded proteins that accumulate in the nerves, heart and ...

AG Mortgage Investment Trust: Q3 Earnings Snapshot

NEW YORK (AP) — NEW YORK (AP) — AG Mortgage Investment Trust Inc. (MITT) on Tuesday reported profit of $20 million in its third quarter. The New York-based company said it had profit of 47 cents per ...

Uranium Royalty: The Market Went Faster Than The Fundamentals

Uranium Royalty boosts liquidity and inventory, gaining full uranium price exposure. Click to know UROY stock's risks, market ...

Core Molding Technologies: Q3 Earnings Snapshot

COLUMBUS, Ohio (AP) — COLUMBUS, Ohio (AP) — Core Molding Technologies Inc. (CMT) on Tuesday reported earnings of $1.9 million in its third quarter. The Columbus, Ohio-based company said it had profit ...

EQV Ventures Acquisition Corp - Ordinary Shares - Class A

EQV Ventures Acquisition Corp. is a blank check company. It was formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar ...

Are NFTs The Future Of Digital Ownership In The Age Of Blockchain And Web3?

NFTs represent a sea-change moment in our digital evolution: powered by Blockchain and Web3, they offer new ways to determine ...